Literature DB >> 17425914

Technology and intensive management in youth with type 1 diabetes: state of the art.

Jamie R Wood1, Lori M B Laffel.   

Abstract

Recent implementation of technologic advances in the management of pediatric type 1 diabetes creates an exciting time for the diabetes community. Safety and efficacy of new therapies are commonly demonstrated first in adult patients with pediatric studies following. This review covers recent advances in six main areas: blood glucose monitoring including continuous monitoring; point-of-care A1c testing; designer insulins; insulin delivery systems including insulin pumps; electronic communication; and telehealth.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17425914     DOI： 10.1007/s11892-007-0019-1

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN： 1534-4827            Impact factor:   5.430


  52 in total

1.  Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. U.S. Study Group of Insulin Glargine in Type 1 Diabetes.

Authors:  R E Ratner; I B Hirsch; J L Neifing; S K Garg; T E Mecca; C A Wilson
Journal:  Diabetes Care       Date:  2000-05       Impact factor: 19.112

2.  The DAILY (Daily Automated Intensive Log for Youth) trial: a wireless, portable system to improve adherence and glycemic control in youth with diabetes.

Authors:  Vikram S Kumar; Katherine J Wentzell; Tarjei Mikkelsen; Alex Pentland; Lori M Laffel
Journal:  Diabetes Technol Ther       Date:  2004-08       Impact factor: 6.118

Review 3.  Insulin analogues.

Authors:  Irl B Hirsch
Journal:  N Engl J Med       Date:  2005-01-13       Impact factor: 91.245

4.  Impact of active versus usual algorithmic titration of basal insulin and point-of-care versus laboratory measurement of HbA1c on glycemic control in patients with type 2 diabetes: the Glycemic Optimization with Algorithms and Labs at Point of Care (GOAL A1C) trial.

Authors:  Laurence Kennedy; William H Herman; Poul Strange; Anthony Harris
Journal:  Diabetes Care       Date:  2006-01       Impact factor: 19.112

5.  Effect of long-term monitoring of glycosylated hemoglobin levels in insulin-dependent diabetes mellitus.

Authors:  M L Larsen; M Hørder; E F Mogensen
Journal:  N Engl J Med       Date:  1990-10-11       Impact factor: 91.245

6.  Indwelling catheters used from the onset of diabetes decrease injection pain and pre-injection anxiety.

Authors:  Ragnar Hanas; Peter Adolfsson; Karin Elfvin-Akesson; Lars Hammarén; Rosita Ilvered; Inger Jansson; Calle Johansson; Marianne Kroon; Jan Lindgren; Agne Lindh; Johnny Ludvigsson; Lars Sigström; Annica Wiik; Jan Aman; Iner Jansson; Annica Wilk
Journal:  J Pediatr       Date:  2002-03       Impact factor: 4.406

Review 7.  Blood glucose monitoring technology: translating data into practice.

Authors:  Irl B Hirsch
Journal:  Endocr Pract       Date:  2004 Jan-Feb       Impact factor: 3.443

8.  Insulin detemir is characterized by a consistent pharmacokinetic profile across age-groups in children, adolescents, and adults with type 1 diabetes.

Authors:  Thomas Danne; Kerstin Lüpke; Kerstin Walte; Wolfgang Von Schuetz; Mari-Anne Gall
Journal:  Diabetes Care       Date:  2003-11       Impact factor: 19.112

9.  Continued use of an integrated meter with electronic logbook maintains improvements in glycemic control beyond a randomized, controlled trial.

Authors:  Lori M B Laffel; William C Hsu; Janet B McGill; Luigi Meneghini; Lisa K Volkening
Journal:  Diabetes Technol Ther       Date:  2007-06       Impact factor: 6.118

10.  Improved glycemic control in intensively treated type 1 diabetic patients using blood glucose meters with storage capability and computer-assisted analyses.

Authors:  S M Strowig; P Raskin
Journal:  Diabetes Care       Date:  1998-10       Impact factor: 19.112
View more
  5 in total

Review 1.  Developmental changes in the roles of patients and families in type 1 diabetes management.

Authors:  Jessica T Markowitz; Katharine C Garvey; Lori M B Laffel
Journal:  Curr Diabetes Rev       Date:  2015

2.  Impact of type 1 diabetes mellitus on the family is reduced with the medical home, care coordination, and family-centered care.

Authors:  Michelle L Katz; Lori M Laffel; James M Perrin; Karen Kuhlthau
Journal:  J Pediatr       Date:  2011-12-01       Impact factor: 4.406

3.  Contemporary rates of severe hypoglycaemia in youth with type 1 diabetes: variability by insulin regimen.

Authors:  M L Katz; L K Volkening; B J Anderson; L M Laffel
Journal:  Diabet Med       Date:  2012-07       Impact factor: 4.359

Review 4.  Technology to optimize pediatric diabetes management and outcomes.

Authors:  Jessica T Markowitz; Kara R Harrington; Lori M B Laffel
Journal:  Curr Diab Rep       Date:  2013-12       Impact factor: 4.810

5.  A novel method for measuring patients' adherence to insulin dosing guidelines: introducing indicators of adherence.

Authors:  Massoud Toussi; Carine Choleau; Gérard Reach; Michel Cahané; Avner Bar-Hen; Alain Venot
Journal:  BMC Med Inform Decis Mak       Date:  2008-12-05       Impact factor: 2.796
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.